AN2 Therapeutics Inc.

ANTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.53

-$0.16 (-3.41%)

At close: Oct 30, 2026, 4:00 PM ET

$4.53

$0.00 (0.00%)

Pre-market: Nov 2, 2026, 5:27 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	-35.17M	-51.32M	-64.73M	-40.96M	-21.54M	-13.6M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	6.25M	8.34M	8.41M	4.39M	974K	40K
Other Working Capital	460K	-3.64M	5.28M	1.22M	-385K	1.14M
Other Non-Cash Items	-1.07M	-3.28M	-2.8M	-615K	53K	6.98M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	164K	-3M	5.83M	3.72M	32K	1.22M
Operating Cash Flow	-29.83M	-49.26M	-53.29M	-33.46M	-20.48M	-5.36M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-46.19M	-46.75M	-132.18M	-93.84M	-77.27M	n/a
Sales Maturities Of Investments	74.5M	101.34M	88.9M	72.07M	27.25M	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	28.31M	54.59M	-43.28M	-21.77M	-50.02M	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	465K	-11K	-1.2M	64K
Financial Cash Flow	113K	372K	84.99M	70.36M	78.54M	3.84M
Net Cash Flow	-1.41M	5.7M	-11.57M	15.12M	8.03M	-1.53M
Free Cash Flow	-29.83M	-49.26M	-53.29M	-33.46M	-20.48M	-5.36M
Adj. Free Cash Flow	-36.08M	-57.6M	-61.7M	-37.85M	-21.46M	-5.4M
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-29.83M	-49.26M	-53.29M	-33.46M	-20.48M	-5.36M